Pulse Biosciences Shares Surge 40%

Core Viewpoint - Pulse Biosciences, Inc. (PLSE) shares experienced a significant increase of 40.91 percent, rising by $5.60 to reach $19.29, likely due to the release of positive clinical data regarding the treatment of atrial fibrillation using its nPulse Cardiac Catheter [1]. Group 1 - The stock price opened at $14.95 and fluctuated between an intraday low of $14.72 and a high of $19.70 on the Nasdaq [2]. - Trading volume surged to approximately 0.65 million shares, significantly higher than the average daily volume of around 0.18 million shares [2]. - The first-in-human feasibility study successfully treated 150 patients with rapid procedure times and minimal adverse effects, with the data presented at the 31st Annual AF Symposium 2026 in Boston [2]. Group 2 - The stock is currently trading within its 52-week range of $12.56 to $22.75 [3].